Novel Agent Promising as Add-On Epilepsy Treatment Phase IIb trial shows benefit for the most common type of epileptic seizures Oct 09, 2023
Weight-Loss Drug Benefit Spans HFpEF, HFmrEF STEP-HFpEF trial results come out consistent across ejection fraction Oct 08, 2023
Managing Heart Failure Comorbidities Hypertension, atrial fibrillation, type 2 diabetes, and anemia care may require adjustment in HF Oct 02, 2023
For Your Patients: Managing Heart Failure With Other Chronic Conditions Having a combination of HF and other medical issues can impact how you approach each of them Oct 02, 2023
No Benefit to Tight Glucose Control in ICU Trial attempts to settle the controversy once and for all Sep 29, 2023
FDA Reviewers Say OTC Decongestant Doesn't Work But they acknowledge that taking the only shelf-accessible product off the market raises issues Sep 07, 2023
Vaccines Not Linked to MS Flare-Ups Nationwide French study might clear up a decade of doubts Sep 05, 2023
No Aspirin After PCI? Extended P2Y12 Monotherapy? Trials Weigh In Two trials read out, but generalizability is the question Aug 29, 2023
Novel Amyloid Drug Improves Mid-Term Outcomes in ATTR Cardiomyopathy Pivotal trial "suggests the tantalizing possibility of genuine clinical improvement" Aug 29, 2023